News

New FDA chief offers support for Kennedy on autism claims, says no more ‘mass cuts’ planned
US Food and Drug Administration Commissioner Dr. Marty Makary suggested in a new interview that autism is caused by a range ...
Fierce Pharma12h
FDA moves to block biopharma employees from serving on advisory committees
Employees of companies regulated by the FDA—such as pharmas or biotechs—are no longer allowed to serve as members of FDA ...
WKRG on MSN12h
FDA hiring contractors to replace terminated safety inspection staffers
When Health Secretary Robert F. Kennedy Jr. announced sweeping job cuts at his department last month, he said that safety ...
FDA Commissioner Dr. Makary: Science Is Based On Challenging Deeply Held Assumptions Where There's No Good Evidence
SiriusXM 'Megyn Kelly Show,' host Megyn Kelly is joined by FDA Commissioner Dr. Marty Makary to discuss his new policy limiting who can serve as members on FDA advisory committees, his efforts to ...
STAT13h
Pharmalittle: We’re reading about FDA layoffs hurting user fee programs, pharma tariffs, and more
The FDA will remove industry representatives from advisory committees and replace them with patients and caregivers ...
STAT14h
A very good day for Lilly, and a bad day for Novo
In a new First Opinion essay, Borio and Krause, both once top FDA officials, say the commissioner made a “rookie misstep” in ...
FDA hiring contractors to replace fired staff who supported safety inspections
When Health Secretary Robert F. Kennedy Jr. announced sweeping job cuts at his department last month, he said that safety ...
BioSpace14h
FDA Moves to Restrict Industry Influence on Advisory Committees
Industry representatives will still be allowed at these meetings, but they will no longer have a spot on the advisory ...
STAT18hOpinion
Five priorities to remake the FDA in a time of deep uncertainty
Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...
STAT1d
Makary says FDA will remove pharma representatives from advisory panels
WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them ...
New restrictions continue to shift US abortion landscape, report shows
The abortion policy landscape continues to shift in the United States, with key changes in how and where women accessed care ...
STAT4d
FDA plans to phase out animal testing in drugs in what it calls a ‘paradigm shift’
The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...